ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections

January 30, 1998

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

In Brief: GAO Studying Cancer Program So Congress Will Have Own Data; NCI Job Freeze Still Hurts Program

February 21, 1975

Report Urges NCI: No Unfunded Mandates for Cancer Centers

October 18, 1996